From : Ripple Vaghashia <ripple@globelapharma.com>
To : MNIKOLEISHVILI@moh.gov.ge
Subject : CPHI 2018
Cc : Priyank Vaghashia <priyank@globelapharma.com>
Received On : 27.11.2018 15:15
Attachments :
Subject: Meeting at CPHI India – 12th to 14th dec , 2018
 
Greetings from GLOBELA PHARMA PVT LTD, INDIA !!
 
We take opportunity to invite you at our stall – CPHI INDIA , We are at Hall -7 , stall 75&76, 
 
We would like to discuss further on the ongoing business or the future venture. 
 
Kindly find our company profile as below, attached is our company presentation and Product list for your reference:
 

GLOBELA PHARMA PVT LTD.  Is an ISO, c-GMP, WHO-GMP accredited manufacturing company at Surat, Gujarat, India. Globela facility to manufacture high quality Pharmaceutical formulations in various forms, like Tablets, Capsules, ORS(Dry Powder) etc. The company is managed by a team of highly qualified and experienced technocrats in R&D, Q.A., Q.C. and production divisions. The company is inspected and approved by following international drug authority.

A : Finish Formulation ( General section )  - tablets , Capsules  , Oral Powder  More than 200 Molecules with dossier available for – African country , Asian country  , Latin America.

B : Finish Formulation (ONCOLOGY )  - tablets , Capsules  ,30 Molecules with dossier available for – African country , Asian country  , Latin America.
 
Global Presence
 
Our Products are Marketed globally and strong portfolio of Business. Geographies and product gives us an edge in an increasingly competitive Market and allows us to provide affordable Medication to people across the world, regardless of geographic and socioeconomic barriers .
 
Over the Years we have built an expertise in understanding the regulatory frameworks of the various countries in which we operate.
 
We are exporting our products more than 27  countries through its dedicated distribution network worldwide.
Approvals and certification
 
Globela pharma manufacturing facility is approved by WHO-GMP, , ISO 9001  Certifications, Our facility has approvals from various countries authorities .
 
Ministry of Health- Yemen
Ministry de la sante – Ivory Coast (DPML)
Ministry of Health- RD Congo
Ministry of Health – Tanzania  (TFDA)
Ministry of Health –Nigeria ( NAFDAC )
Ministry of Health – Kenya (PPB)
Ministry of Health – UGANDA
Ministry of Health – GHANA ( FDA)
 
Our overseas presence:
 
Asia
AFRICA
MIDDLE EAST
CIS
Latin America
 
 
 
 
 
 
Philippines
GHANA
Yemen
Costa Rica
 
Vietnam
Congo
 Syria
Uzbekistan
 Bolivia
 
India
Ivory Coast
 
Kazakhstan
 Central america
 
Nepal ,Bhutan
TANZANIA
 
Kyrgyzstan
 
 
Afghanistan
Nigeria
 
 
 
 Srilanka
Kenya
 
Tajikistan
 
 
 Myanmar 
Uganda
 
Azerbaijan
 
 
 Combodia
 
Armenia
 
 
 
Looking forward to your kind response !!


Priyank Vaghashia
Chief Operating Officer
Globela Pharma LLC

Tel: (888)588-8511      

******************************************************************************************** 
CONFIDENTIAL: This email, including attached files, may contain confidential information and is intended only for the use of the individual and/or the entity to which it is addressed. If you are not the intended recipient, disclosure, copying, use, or distribution of the information included in this email is prohibited. Please immediately and permanently delete this email and notify sender of mistake. Thank you 
*******************************************************************





This email message (including attachments) contains information which may be confidential and/or legally privileged. Unless you are the intended recipient, you may not use, copy or disclose to anyone the message or any information contained in the message or from any attachments that were sent with this email, and if you have received this email message in error, please advice the sender by email, and delete the message. Unauthorized disclosure and/or use of information contained in this email may result in criminal liability.

Everything in this e-mail and attachments relating to the official business of GLOBELA PHARMA PRIVATE LIMITED is proprietary to the company.

Caution should be observed in placing any reliance upon any information contained in this e-mail, which is not intended to be a representation or inducement to make any decision in relation to GLOBELA PHARMA PRIVATE LIMITED. Any decision taken based on the information provided in this e-mail, should only be made after consultation with appropriate legal, regulatory, tax, technical, business, investment, financial, and accounting advisors.

The e-mail address of the sender may not be used, copied, sold, disclosed or incorporated into any database or mailing list for spamming and/or other marketing purposes without the prior consent of GLOBELA PHARMA PRIVATE LIMITED. Neither the sender of the e-mail, nor GLOBELA PHARMA PRIVATE LIMITED shall be liable to any party for any direct, indirect or consequential damages, including, without limitation, loss of profit, interruption of business or loss of information, data or software or otherwise.

No warranties are created or implied that an employee of GLOBELA PHARMA PRIVATE LIMITED and/or a contractor of Internet solutions is authorized to create and send this e-mail.